Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc. | Director | Common Stock | 53.2K | $67K | $1.26 | Jun 1, 2024 | Direct |
Aclaris Therapeutics, Inc. | Director | Restricted Stock Units | 4.79K | $4.94K | $1.03 | Jun 6, 2024 | Direct |
Aclaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15.8K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 20, 2023 | 2 | $23.3K | 4 | Jun 22, 2023 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 15, 2023 | 4 | $338 | 4 | Jun 20, 2023 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2023 | 4 | $0 | 4 | Jun 5, 2023 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 2, 2022 | 4 | $0 | 4 | Jun 6, 2022 | Director |
ACRS | Aclaris Therapeutics, Inc. | Jun 3, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |